Biotechnology Ozempic Maker Strikes $11B Deal With Catalent As It Rushes To Meet Massive Weight-Loss Drug Demand – Catalent (NYSE:CTLT), Novo Nordisk (NYSE:NVO) Maker of ‘miracle’ weight loss drugs Ozempic and Wegovy, Novo Nordisk A/S NVO has announced the acquisition of three fill-finish… February 6, 2024 Read more